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Background: There have been no local studies on the duration and risk factors for vancomycin-resistant
enterococcus (VRE) colonization in a postacute convalescence hospital. Our aim was to investigate the
duration of VRE colonization and risk factors for prolonged carriage among patients admitted to a
convalescence hospital.
Methods: The case records of patients admitted to a 400-bed convalescence care hospital with rectal
swab or stool culture samples positive for VRE from January 2010 to December 2014 were retrieved. The
clinical characteristics associated with clearance of colonization within the hospitalization period were
analyzed, and logistic regression was set up to detect for factors associated with inpatient and 1-year
mortality.
Results: A total of 121 patients (mean age, 81.45 years) were colonized with VRE. The inpatient clearance
rate was only 35.5%. The median time to VRE clearance during the hospital stay was 43 days. The in-
dependent predictors for VRE colonization during hospitalization were old-age-home residents [odds
ratio (OR)¼ 2.72; 95% conﬁdence interval (CI), 1.14e6.48] and antibiotics use (OR¼ 4.27; 95% CI, 1.89
e9.62). Inpatient mortality was higher among those with persistent VRE colonization upon discharge
(39.7% vs. 18.6%, p¼ 0.017). Presence of wound or bed sores (OR¼ 4.58; 95% CI, 1.16e13.2), chair/bed
bound status (OR¼ 3.64; 95% CI, 1.27e10.46), and persistent VRE colonization (OR¼ 12.4; 95% CI, 3.16
e42.52) were predictors for 1-year mortality.
Conclusion: The strongest risk factor for prolonged VRE carriage was old-age-home residents. Survival is
adversely affected by VRE carriage and functional mobility. Patients with these factors should be
managed more carefully, and active surveillance should be focused on this high-risk group to prevent
spread of transmission.
Copyright © 2016, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. Published by Elsevier Taiwan
LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
It has been widely reported that there is an increasing preva-
lence of multidrug-resistant bacteria in acute care hospitals. Re-
ports from the National Healthcare Safety Network in America
found that up to 16% of all healthcare-associated infections (HAI)tion and Extended Care, 124
inical Gerontology & Geriatrics. Pub
d/4.0/).were associated with the following multidrug-resistant pathogens:
methicillin-resistant Staphylococcus aureus (MRSA; 8% of HAIs),
vancomycin-resistant Enterococcus faecium (4%), carbapenem-
resistant Pseudomonas aeruginosa (2%), extended-spectrum ceph-
alosporin-resistant K. pneumoniae (1%), extended-spectrum ceph-
alosporin-resistant Escherichia coli (0.5%), and carbapenem-
resistant Acinetobacter baumannii, Klebsiella pneumoniae, Klebsi-
ella oxytoca, and E. coli (0.5%).1 There is no formal report on the
prevalence of VRE in Hong Kong. A recent survey conducted by the
Hong Kong Hospital Authority that screened all patients who had a
history of hospitalization in other hospitals/clusters in the past 3lished by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
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target screening on admission was 1.4%, ranging from 0.2% to 1.7%
across hospital clusters. The positive rate for old-age-home resi-
dents was 2.4%.2 This percentage is low compared with other re-
ports. In 1990 in the United States, the prevalence of VRE was less
than 5%,3 but this increased to 33.3% in 2006e2007.1 Similarly, in
Korea, VRE increased from 2.9% in 1997 to between 17% and 21% in
2007.4 Transfer of patients between institutions will result in
regional dissemination of resistant organisms.5 Transfer of patients
between acute hospital and postacute care facilities created a cycle
for the ongoing introduction of antibiotics-resistant bacteria. VRE
infections are associated with high healthcare costs, as well as
increased morbidity and mortality.6 Risk factors associated with
increased VRE colonization include presence of a serious comorbid
condition, immune-compromised individual, prolonged hospital
stay, residing in long-term care facility, proximity to another colo-
nized or infected patient, invasive procedures, and the use of broad-
spectrum antibiotics or vancomycin.7 Persistent colonization with
VRE can result in prolonged use of contact precaution for the pa-
tients and limits the chance for rehabilitation.
Many studies have focused on the epidemiology, natural history,
and risk factors of VRE infection/colonization in hospitalized pa-
tients and long-term care facilities.8,9 However, limited information
is available on the duration of VRE colonization and the factors that
are associated with VRE clearance. The objective of this study is to
determine the risk factors for colonization and to analyze the
predictors for VRE clearance among the inpatients of a postacute
care facility.
2. Methods
The study was conducted in a postacute care hospital in Hong
Kong. The 400-bed unit provides convalescence and rehabilitation
services to patients transferred from an acute regional hospital in
Hong Kong. A retrospective review of the patients’ medical records
covering the period of January 2010 to December 2014 was per-
formed. The inclusion criteria included patients whowere admitted
to the unit with VRE colonization or the date of positive culture for
those patients acquiring the organism in the postacute care hos-
pital through target screening using either rectal swab or stool
culture. The assessment of VRE colonization was based on the
absence of acute infection clinically and laboratory evidence by the
doctor in charge of the case and the infection control nurse. The
medical records were reviewed from the date of initial VRE isola-
tion until December 31, 2014. Basic demographic information, place
of residence prior to admission, mobility status as deﬁned by walk
unaided, walk with aids, and chair or bed bound on admission and
discharged were recorded. Other variables collected include
admission to an acute care hospital in the past 3 months, primary
diagnosis, date of admission, date of discharge, comorbidity as
measured by Charlson comorbidity index,10 intravenous antibiotics
use and duration of use during the index hospitalization period,
presence of wound or decubitus ulcer, use of intravenous catheter,
indwelling Foley, feeding tube or tracheostomy and number of days
in use of these tubes, history of surgery or invasive procedure
during the index admission, acquisition of other antibiotics-
resistant organisms including MRSA, extended-spectrum beta lac-
tamase (ESBL) producing E. coli and Klebsiella and Clostridium
difﬁcile. VRE colonization or carriage was deﬁned by rectal swab or
stool culture positive for VRE, whereas prolonged VRE carriage or
persistence carriage or colonizationwas deﬁned as persistent rectal
or stool culture positivity after discharge fromhospital. Clearance of
VRE was deﬁned by VRE negative rectal or stool culture on at least
three consecutive samples taken at 1 week apart or longer.11 The
date of clearance was the date of the third negative culture.The date of the ﬁrst positive VRE culture was used to calculate
the duration of colonization. Censored cases were deﬁned as death
or loss to follow-up.
2.1. Microbiological method
Rectal swabs specimens were cultivated on chromogenic agar,
and enterococci were identiﬁed with a conventional method
including Gram staining and determination of colonial morphology
and biochemical and growth characteristics. In vitro susceptibility
to vancomycin was tested according to Clinical and Laboratory
Standards Institute (CLSI) guidelines, using agar dilution method
and Becton Dickinson Biosystems. The editions of CLSI “Perfor-
mance Standards for Antimicrobial Susceptibility Testing” were as
follows:
(1) CLSI. Performance Standards for Antimicrobial Susceptibility
Testing; Twenty-Fourth Informational Supplement. CLSI
Document M100-S24. Wayne, PA. Clinical and Laboratory
Standards Institute; 2014
(2) CLSI. Performance Standards for Antimicrobial Susceptibility
Testing; Twenty-Third Informational Supplement. CLSI
Document M100-S23. Wayne, PA. Clinical and Laboratory
Standards Institute; 2013
(3) CLSI. Performance Standards for Antimicrobial Susceptibility
Testing; Twenty-Second Informational Supplement. CLSI
Document M100-S22. Wayne, PA. Clinical and Laboratory
Standards Institute; 2012
(4) CLSI. Performance Standards for Antimicrobial Susceptibility
Testing; Twenty-First Informational Supplement. CLSI
Document M100-S21. Wayne, PA. Clinical and Laboratory
Standards Institute; 2011
(5) CLSI. Performance Standards for Antimicrobial Susceptibility
Testing; Twentieth Informational Supplement (Update). CLSI
Document M100-S20-U. Wayne, PA. Clinical and Laboratory
Standards Institute; 2010
(6) CLSI. Performance Standards for Antimicrobial Susceptibility
Testing; Twentieth Informational Supplement. CLSI Docu-
ment M100-S20. Wayne, PA. Clinical and Laboratory Stan-
dards Institute; 2010
This study was approved by the hospital cluster regional ethical
committee.2.2. Statistical method
Descriptive statistics on baseline demographic information
were made. Factors affecting VRE clearance within the hospitali-
zation period were tested with chi-square test for categorical data
and t test or ManneWhitney U test for continuous data.
Logistic regression was set up to look for predictors of within
hospitalization VRE clearance. Predictors of inpatient mortality and
1-year mortality were determined after adjusting for variables that
were signiﬁcant in univariate analysis using stepwise logistic
regression analysis. A p value of less than 0.05 was considered
statistically signiﬁcant.3. Results
A total of 121 patients with positive VRE cultures were identiﬁed
during the period of January 2010 to December 2014. Their mean
age was 81.45 (standard deviation, 10) years, and 94 (77.7%) were
male. Seventy-two (59.5%) could either walk unaided or walk with
Table 2
Logistic regression for predictors of VRE clearance during hospitalization period.
OR 95% CI
Antibiotics use 4.27 1.89e9.62
Old-age-home residents 2.72 1.14e6.48
CI¼ conﬁdence interval; OR¼ odds ratio; VRE¼ vancomycin-resistant enterococci.
Table 3
Logistic regression for predictors of 1-year mortality.
OR 95% CI
Presence of wound/bed sores 4.58 1.16e13.2
Chair/bed bound status 3.64 1.27e10.46
Persistent VRE upon discharge 12.4 3.16e42.52
CI¼ conﬁdence interval; OR¼ odds ratio; VRE¼ vancomycin-resistant enterococci.
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(38.8%) were residing in old-age homes prior to admission, and
69 (57%) have a history of hospitalization within the past 3 months
prior to the index admission. The median Charlson comorbidity
index was 2 (interquartile range, 2e3). Majority of these patients
were transferred from acute hospitals (96.7%). Themedian duration
of hospital stay was 41.5 days.
For concomitant infection of multidrug-resistant organisms, 20
(16.5%) have MRSA colonization, 14 (11.6%) have ESBL pathogens,
and six (5%) have C. difﬁcile infection.
Forty-three patients (35.5%) were considered “cleared” of VRE
colonization during hospital stay, and 78 (64.5%) had clearance of
VRE within the observation period. The median time to VRE
clearance during hospitalization was 43 days. Inpatient mortality
was 39 (32.2%). One-year mortality was 68 (56.2%) and 2-year
mortality was 71 (58.7%). Table 1 shows the basic demographic
information and factors favoring VRE clearance during hospital
stay. Univariate analysis found that poor mobility status, old-age-
home residents, and antibiotics use were factors contributing to
failure to clear VRE colonization during hospitalization. Stepwise
logistic regression using variables that are signiﬁcant in the uni-
variate analysis found that use of antibiotics [odds ratio (OR)¼ 4.27,
p < 0.001; 95% conﬁdence interval (CI), 1.89e9.62] and old-age-
home residents (OR ¼ 2.72, p ¼ 0.024; 95% CI, 1.14e6.48) were
independent predictors of failure to clear VRE during hospitaliza-
tion (Table 2).
Among those who survived up to hospital discharge, it has been
found that the duration of hospital stay was longer among those
who had been “cleared” of VRE colonization during hospitalization
than those who had not (98.2 vs. 42.3 days; p ¼ 0.003; 95% CI,
20.5e91.4).
Inpatient mortality was higher among those who failed to have
their VRE cleared (39.7% vs. 18.6%, p¼ 0.017). Logistic regression
found that failure to clear VRE colonization during hospital stay
(OR¼ 2.9, p¼ 0.034; 95% CI, 10.8e7.84) and history of intravenous
catheter use (OR¼ 5.62, p< 0.001; 95% CI, 2.28e13.82) were sig-
niﬁcant predictors of inpatient mortality. There was no signiﬁcant
difference in 1-year mortality (60.3% vs. 48.8%, p¼ 0.254), whereas
2-yearmortality is signiﬁcantly higher among thosewith persistent
VRE colonization on discharge (83.7% vs. 44.9%, p< 0.001). Logistic
regression showed that the presence of wound or bed sores
(OR¼ 4.58, p¼ 0.005; 95% CI, 1.16e13.2), chair/bed bound status
(OR¼ 3.64, p¼ 0.016; 95% CI, 1.27e10.46), and persistent VRE
colonization upon discharge (OR¼ 12.4, p< 0.001; 95% CI,
3.16e42.52) were predictors for 1-year mortality (Table 3).Table 1
Demographic information and VRE clearance during hospitalization.
VRE clearance during hospitalization
Age (y), mean (SD) 80.88 (10.6)
Charlson comorbidity index 2.44 (1.6)
Male sex 81.4%
Chair/bed bound status 23.3%
Old-age-home residents 23.6%
History of hospitalization in the past 3 mo 55.8%
Days of hospitalization, mean (SD) 43.6 (46.2)
Antibiotics use 37.2%
Presence of wound 46.5%
Use of venous catheter 33.3%
Presence of Foley 20.9%
Presence of Ryles tube 23.3%
History of invasive procedures/surgery 27.9%
MRSA colonization 14.3%
ESBL pathogen infection 11.9%
Clostridium difﬁcle infection 4.8%
ESBL¼ extended spectrum beta lactamase producing Escherichia coli and Klebsiella
VRE¼ vancomycin-resistant enterococci.4. Discussion
This study showed the epidemiology and risk factors of VRE
carriage among patients in a postacute convalescence care hospital.
For our cohort, the median time to clearance for VRE during hos-
pitalization was 43 days. VRE colonization has been shown to be
persistent for up to 6 months with a median duration of coloni-
zation of 67 days in long-term care facility residents.12 Factors that
contribute to persistent of VRE colonization in our study were old-
age-home residents and antibiotics use. Majority of our patients
were transferred from acute hospitals with multiple comorbidities.
It is well described in the literature that patients in acute hospital
setting are prone to multiple microbial infections, and thus it is not
uncommon for patients from acute hospitals to harbor VRE.
Studies8,13 have found that antimicrobial therapy, admission to
acute care facility, prolonged duration of hospitalization and
intensive care or prolonged stay in long-term care facilities, and a
moderate to severe level of dependency were associated with VRE
colonization.
Antibiotics usewas an important risk factor for VRE colonization
in our study. There is growing evidence that the prevalence of
antibiotics-resistant pathogens is associatedwith selectionpressure
caused by antibiotics use.14 This is shown in our study, in that 58.6%
of the study population did receive antibiotics during their stay in
our unit. Among them, only 22.5% cleared VRE colonization during
hospitalization. Evidence has shown that the use of agents other
than vancomycindsuch as extended-spectrum cephalosporins,
quinolones, and antimicrobials against anaerobesdis associated(N¼ 43) No VRE clearance during hospitalization (N¼ 78) p
81.77 (9.7) 0.644
2.74 (1.7) 0.337
75.6% 0.461
50% 0.004
46.2% 0.026
57.7% 0.842
97.4 (91.7) 0.003
70.5% <0.001
42.9% 0.656
36.4% 0.741
26.9% 0.465
26.9% 0.658
17.9% 0.202
17.9% 0.608
11.5% 0.952
5.1% 0.93
; MRSA¼methicillin-resistant Staphylococcus aureus; SD¼ standard deviation;
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spectrum antibiotics should be reinforced.
Antibiotics use was the single notable factor for VRE coloniza-
tion during hospitalization. However, confounding variables do
exist. Patients' underlying disease and immunocompromised state
need to be considered together with antibiotics use. The complex
nature of coexisting medical problems, antibiotics selection, and
duration of therapy all played an interacting role in the acquisition
of VRE colonization.
There is a high proportion of patients with poor mobility status
and old-age-home residents who have acquired VRE colonization.
Logistic regression showed that old-age-home residents were an
independent predictor of VRE colonization. The migration of
resistant pathogens into old-age homes occurs when residents
arrive after being discharged from a hospital. These groups of pa-
tients are a contributing factor to a proportion of participants with
greater morbidity and higher hospitalization rate compared with
others. Carriers of resistant microorganisms among them served as
a source of further spread of the resistant organism(s) to others.
Therefore, this group of high-risk individuals should be screened
for drug-resistant microorganisms when they are admitted to
hospitals, and infection control policies should be reinforced in old-
age homes.
Studies have proved that VRE colonized patients have poorer
prognosis.16 The inpatient and 1-year mortality is higher among
those with persistent VRE upon discharge. A high proportion of
participants who are chair/bed bound were residing in old-age
homes, and those who have greater level of dependency are less
likely to have their VRE cleared than those who are more mobile
(20.4% vs. 45.8%, p ¼ 0.004) during their hospital stay. Interactions
exist among those who have poor mobility status, old-age-home
residents, and those who have VRE colonization. Those with poor
mobility status generally come from old-age homes, a situation that
in turn leads to a high risk of developing VRE colonization. These
are a group of individuals who require more nursing care and
therefore are more susceptible to VRE cross-transmission. Precau-
tion should therefore be takenwhen dealingwith this group of frail,
highly dependent and old-age-home residents so as to prevent
cross-transmission and outbreak in acute and postacute convales-
cence care hospitals.
In our study, VRE clearance was deﬁned as VRE culture-negative
cultures in three consecutive samples taken at least 1 week apart or
longer.9 The sensitivity of a single stool/rectal swab culture was
79%, and the cumulative sensitivity increased to 99.1% for detecting
VRE with three cultures.17 However, in another study, the sensi-
tivity of rectal swab culture was only 58%.18 In a study by Huckabee
et al,19 after one, two, and three VRE cultures, the percentage of
negative cultures was 52%, 68%, and 72%, respectively. Sohn et al20
showed that after one negative follow-up culture, the next one was
negative in 93.8%, and after two negative cultures, 93.2% remained
culture-negative. Therefore, long follow-up testing intervals and
the techniques used to obtain the specimens may explain the
relatively high negative follow-up culture rate. In our study, two of
our cases were culture positive again after three consecutive
negative cultures. In a study by Park et al,21 two out of six chronic
hemodialysis patients and 10 of the 36 nonhemodialysis patients
were found to have positive culture again after three consecutive
negative cultures. Therefore, we need to monitor those who were
previously colonized, high-risk patients to check for the possible
reemergence of VRE. False negative rate as a result of poor sampling
technique and infrequent sampling interval may also contribute to
the increasing prevalence of VRE. In view of this, starting frommid-
2014, the local cluster infection control policy recommended to
screen recently admitted patients who have a history of VRE car-
riage for VRE reemergence. For old-age-home residents who wereVRE carriers, upon discharge from a hospital, monthly rectal swab
screening will be performed to detect their carrier status. For
community-dwelling VRE carriers attending outpatient clinics, day
hospitals, outreach services, and day care, rectal swab for VRE will
be taken routinely.
There are several limitations in this study. Time to VRE clearance
was deﬁned as in other studies,7,11 in which clearance was three
consecutive cultures negative for VRE taken 1 week apart or longer.
In our study, all VRE carriers had their samples taken on a regular
interval only during the inpatient period. However, for those with
persistent VRE colonization who were discharged, there is no reg-
ular interval for sampling. Only when they are readmitted to hos-
pitals or attend follow-up in outpatient clinics will their samples be
taken. If regular testing had been performed after hospital
discharge, negative cultures could have been more rapidly
detected.
As mentioned previously, there is no regular screening for VRE
after the patient has been discharged from the postacute conva-
lescence unit except for old-age-home residents. A retrospective
review of each patient record during the 5-year observation period
contributes to a misclassiﬁcation bias. If the patient did not have
regular follow-up or had never been readmitted to a hospital again
after the index admission, no VRE sampling will be available. This
may lead to a falsely low VRE detection rate. For those patients who
have follow-up arrangements in any clinical setting, the follow-up
interval is very heterogeneous. Clinical information and culture
results were collected retrospectively. All these contribute to an
inaccurate duration of colonization. We also cannot assess the
duration of colonization with regard to whether the VRE was the
same as the previous strain or the patient has acquired a new strain.
Thus, the duration of colonization will be prolonged as the newly
acquired VRE is from another hospital or nursing home.
The guidelines used for VRE colonized patients in a postacute
convalescence unit were the same as in an acute hospital setting.
Use of single room isolation and contact precautions were the
necessary arrangements. However, these factors contribute to
problems in a convalescence hospital. There is limitation in the
number of single rooms that can be used for isolation and contact
precautions. The inability of the patients who were on contact
precautions to participate in rehabilitation activities that involve
physical and social contacts hindered recovery. All these can
interfere with their psychosocial and rehabilitation needs, which in
turn leads to prolonged hospital stay.
Furthermore, no data on travel history were available for record
review, leaving us without any clue regarding the origin of these
VRE isolates.
There have been no guidelines on the decontamination of VRE
colonized patients. In our practice, only patients with septic
symptoms will be started on treatment. Whether the initiation of
antibiotics to eradicate the VRE in asymptomatic patients can lead
to an improvement in prognosis is open for discussion.
Many factors do contribute to survival. Owing to the nature of
the retrospective study, there are inadequate controls for con-
founding variables on survival of our patients. A prospective study
is warranted for further information on this.
5. Conclusion
Our study showed that VRE colonization and carriage duration
were substantially long among a group of patients hospitalized in a
postacute convalescence unit. Themedian duration of carriage is up
to 140 days. Risk factors for VRE colonization include the use of
antibiotics and old-age-home residents. Survival is also affected by
VRE carrier state and functional mobility. Patients with these fac-
tors should be managed more carefully to prevent transmission of
D.K.Y. Miu et al. / Journal of Clinical Gerontology & Geriatrics 7 (2016) 153e157 157infection. Active surveillance should be focused on this high-risk
group of patients to prevent further spread of this resistant
microorganism. With the results of this study, it is advised that
appropriate isolation policy and infection control measures be
implemented so as to reduce the delay in the transfer of patients
with VRE colonization to rehabilitation facilities.Conﬂicts of interest
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